Anti-doping news

The World Conference on Doping in Sport concluded with an outstanding success

The President of the International Weightlifting Federation, Dr. Tamás Aján was reelected as WADA Foundation Board Member. He fulfills his duties as the member of the Board since WADA was set up in 1999. After a two years consultation process the WADA Foundation Board has unanimously accepted the revised Anti-Doping Code and the WADA Executive Committee also agreed to approve the revised International Standards coming into force on 1 January 2015. After the receipt of the new rules it is all Signatories' duty to incorporate the provisions of the Revised Code into their policies, legislation and rules. The development of the modern sport requires a closer cooperation within the stakeholders of the Anti-Doping Community and the Revised Code assures and states their mutual recognition. During the Conference the neutral IWF Anti-Doping Commission held its’ first informal meeting and identified the key areas of the future cooperation. Dr. Patrick Schamasch the Chairman of the IWF Anti-Doping Commission emphasized the importance of a new relevant, efficient and transparent Test Distribution Plan. The meeting was very fruitful and with the expertise of the members the IWF will fight even more effectively against doping. The only candidate to replace the departing John Fahey was the former British Olympic Association chairman and current International Olympic Committee vice-president Sir Craig Reedie. He was confirmed to become the new president of WADA from 1 January

Significant Changes Between the 2009 Code And the 2015 Code, Version 4.0

During the 2015 Code consultation process, 315 separate submissions were received. The submissions recommended a total of 3,987 changes to the Code. In addition, the Code Drafting Team engaged in dozens of face-to-face and telephonic meetings with stakeholders to discuss the Code. Version 4.0 is the fourth published version of the 2015 Code. In between the published versions, more than 50 different working drafts were considered. In some cases, changes from the 2009 Code were made in an early published version and then changed back in a later version based on continuing stakeholder feedback (for example, the initial proposals to eliminate the B Sample and to change the criteria for adding a substance or method to the Prohibited List). In several other cases, changes were made to make the Code language consistent with the legal opinion on Code enforceability provided by Judge Jean-Paul Costa, the former President of the European Court of Human Rights. As was the case with the 2003 and 2009 Codes, stakeholder input was invaluable in making Version 4.0 of the 2015 Code a more clear and effective document. This input has resulted in 2,269 changes between the 2009 Code and Version 4.0 of the 2015 Code. All of these changes are reflected in the document, “Version 4.0 2015 Code redlined to 2009 Code,” which is posted on WADA’s website. This document provides an overview of those changes organized into seven general themes, including the key changes related to each theme. Check out the document

WADA: New steroid profiling program

JOHANNESBURG -- A new urine test designed to catch athletes who take steroids is to be introduced by the World Anti-Doping Agency next year and will be used at the World Cup in Brazil. WADA called it "the twin'' of the blood profiling currently system used in the athletes' biological passport system. It will allow anti-doping authorities to build a profile of a person's steroid levels from urine samples and to identify any changes -- in a similar way that changes in blood may indicate doping. WADA said Tuesday the new technique will particularly target testosterone and will "complement'' the biological passport. It can be used from Jan. 1, WADA President John Fahey said, announcing the introduction of the "steroidal module'' at the World Conference on Doping in Sport in South Africa. FIFA will be one of the first federations to use it. The world football body said later Tuesday it'll be part of its drug testing at next year's World Cup. "FIFA and WADA will ensure the best possible analysis of urine and blood samples and the proper implementation of the new strategy in the fight against doping by means of the steroid module,'' FIFA said. The steroid technique had been developed alongside the current blood module but then fell behind, Fahey said. Blood profiling has been in use since 2008. Blood profiling has had success in detecting the use of the blood-boosting drug EPO and led to the banning of a number of cyclists. It is currently used by around 35 sports, WADA says. WADA has also developed a mobile App that allows athletes to give their whereabouts to anti-doping agencies through their cellphones or other devices so they don't miss out-of-competition tests. The new App will be available from next month.   Copyright 2013 by The Associated

WADA publishes 2014 Prohibited List

Following approval by the World Anti-Doping Agency’s (WADA) Executive Committee on September 11, the 2014 List of Prohibited Substances and Methods is now available. Noteworthy changes to the List, which will come into force on January 1, 2014, include: IN – AND OUT-OF COMPETITION Use of International Non-proprietary Names (INN) With the assistance of the World Health Organisation, the nomenclature of some substances on the List has been updated to International Non-proprietary Names (INN). For ease, however, previous names have been maintained and no substance has been deleted. S1. Anabolic Agents To ensure clarification and accuracy, changes were made to the definitions of “exogenous” and “endogenous”. S2. Peptide Hormones, Growth Factors and Related Substances As made clear through points S2.2, S2.3 and S2.4, Releasing factors are prohibited. Furthermore, other prohibited growth factors are listed separately. S5. Diuretics and other Masking Agents Vasopressing V2 antagonists (vaptans) were added as an example of a diuretic subclass. M1. Manipulation of Blood and Blood Components For the purpose of scientific accuracy, the term allogenic was introduced. IN-COMPETITION S6. Stimulants Some drugs that metabolize to amphetamine or methamphetamine have been reclassified because improved analytical techniques permit the identification of the administered drug and corresponding metabolites; MDMA and MDA are reclassified because they are now recognized as less likely to be used as doping agents; cathinone and its analogues (e.g. mephedrone, methedrone, a- pyrrolidinovalerophenone) and trimetazidine have been added as examples to reflect emerging patterns of drug use. IN PARTICULAR SPORTS P1. Alcohol In the interest of accuracy, changes were made to the wording describing the blood alcohol threshold. In addition, “Aeronautic” has been replaced by “Air Sports”, and “FITA” has been replaced by its new acronym “WA” (World Archery). P2. Beta-blockers “FITA” has been replaced by its new acronym “WA” (World Archery). Monitoring Program In order to detect potential patterns of abuse, mitragynine has been added to the Narcotics class of the Monitoring Program. Mobile-friendly formats In an effort to provide stakeholders with tools to support anti-doping activities and following the successful iPhone application introduced in 2011, the 2014 Prohibited List will again be available on iPhone and other mobile devices as of January 1, 2014. In addition to English, French and Spanish versions of the List, it is also possible to translate the List into other languages. Stakeholders who wish to translate the List can do so by November 1, 2013 and send WADA the new version to be inserted in the mobile-friendly platforms at minimal cost. For more information, please contact: [email protected] To consult the 2014 Prohibited List, the 2014 Monitoring Program, a summary of modifications on the 2014 List, and a Q&A on any changes, please click

WADA 2012 Testing Figures

In accordance with Article 14.5 of the World Anti-Doping Code, WADA has traditionally published two annual sets of testing figures: the first set reported by the WADA accredited laboratories on analyses performed, and the second by Anti-Doping Organizations (ADOs) on their doping control activities. In 2012, for the very first time, figures have been compiled entirely from the Anti-Doping Administration and Management System (ADAMS), the system through which all WADA accredited laboratories report their positive and negative findings. This advanced method of data collation means that there is no longer a requirement for the publication of a second set of testing figures – the separate ADO Testing Figures Report – later in the year. This new report, using ADAMS, combines the laboratory and ADO testing data in urine, blood and Athlete Biological Passport samples, and has allowed for the most transparent reflection of the global state of anti-doping testing to-date. It is important to note that the number of Adverse Analytical Findings (AAFs) and Atypical Findings (ATFs) reported by laboratories may not correspond with the number of Anti-Doping Rule Violations (ADRVs) reported by ADOs. This is because all results are subject to a results management process conducted by ADOs, which includes matching results with Therapeutic Use Exemptions (TUEs) and longitudinal studies. In addition, one single result in the report does not necessarily correspond to one athlete. Results could correspond to multiple findings on the same athlete or measurements performed on the same athlete, such as in the case of longitudinal studies in testosterone. The 2012 Anti-Doping Testing Figures Report is available here Check out the figures for Weightlifting under Table G34: 2012 Anti-Doping Testing Figures - Olympic Sport –

WADA suspends the accreditation of the Rio de Janeiro Laboratory

WADA has suspended the accreditation of the LAB DOP – LADETEC / IQ – UFRJ Doping Control Laboratory (LADETEC) in Rio de Janeiro, Brazil. The suspension, which became effective as of August 8, 2013, prohibits the LADETEC from carrying out any WADA-related anti-doping activities. A further decision regarding possible revocation of the laboratory’s accreditation will be made by WADA’s Executive Committee. More information